Thursday, June 30, 2011

Lilly to Remain Independent; Astellas Lands $609M in Deals - June 30, 2011

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Thursday, June 30, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS

TOP SPONSOR

Our Pharmaceutical & Healthcare Marketing MBA for Executives is thoughtfully designed to accommodate demanding careers and busy travel schedules while remaining true to our tradition of academic excellence and personal achievement. You have the flexibility to enroll in our accelerated Online MBA format or Classroom MBA format.

For more information, please visit: www.sju.edu/epharma
HeadHtml
•  Eli Lilly and Company (LLY) to Remain Independent; Plans 10 Drugs in Final-Stage Trials by Year End More...

More Job Industry News
HeadHtml
•   Astellas Pharma Inc. (YPH.BE) Lands $609 Million in Deals More...
•   Quintiles, Inc. (QTRN) Makes Second Investment in PRANA Biotechnology (PRAN) More...

More Mergers and Acquisitions News
HeadHtml
•  Noble Life Sciences Inc. Announces the Formation of Its Investment Group, BlackRock BioCapital, LLC More...

More New Company News
HeadHtml
•   Lotus Tissue Repair Pioneers New Treatment for Rare and Disfiguring Disorder, Raises $26 Million From Third Rock More...

More Startup News
HeadHtml
•   Sorbent Therapeutics, Inc. Completes $36 Million Series B Financing for Net of $53 Million More...
•   Emisphere Technologies, Inc. (EMIS) Announces Agreements to Raise $7.5 Million in Private Placement Transactions More...

More Finance News
HeadHtml
•   Valeant Pharmaceuticals International (VRX) Announces License Agreement With Meda AB (MDABF.PK) for North American Rights for Elidel(R) and Xerese(TM) More...
•   Pfizer Inc. (PFE) Signs Deal With Russian Venture Capital Firm For R&D More...
•   BioPontis Alliance LLC Enters into Translational Technology Development Agreement with Pfizer Inc. (PFE) More...
•   Scil Proteins GmbH Signs Licensing and Pre Manufacturing Agreement with Anabasis/Domp© for Eye Indications More...
•   MediciNova, Inc. and Zhejiang Medicine Company Group Finalize Agreement for Joint Venture in China More...

More Alliances News

•   Tengion Inc. CEO Quits; Firm to Send FDA More Data More...
•   NeoStem, Inc. Announces the Addition of Joseph Talamo as Vice President, Corporate Controller and Chief Accounting Officer More...
•   Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos More...
•   LifeScience Alley® Hires Shaye Mandle as Vice President of Government and Affiliate Relations More...

More Personnel News
Tower: Facebook
HeadHtml
•   Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results for the Fiscal Year Ended March 31, 2011 More...
•   First China Pharma (FCPG.OB) Provides Guidance Regarding Fiscal 2010 Results More...
•   Hamilton Thorne, Inc. Files Revised Q1 2011 Financial Statements More...
•   Hi-Tech Pharmacal (HITK) to Release Fourth Quarter Earnings and Hold Conference Call on July 7, 2011 More...
•   ReNeuron - Preliminary Results for the Year Ended 31 March 2011 More...

More Earnings Report News
HeadHtml
•   IMPAX Laboratories, Inc. (IPXL) Announces Settlement of Litigation Relating to WELCHOL(R) Tablets and WELCHOL(R) Oral Suspension Products More...

More Legal News
HeadHtml
•   FDA Approves Dendreon Corporation (DNDN)'s Los Angeles Cancer Immunotherapy Manufacturing Facility More...

More Construction News
 
Real Estate



29 Acre Development Site For Rent
3300 Plymouth Road
Ann Arbor, Michigan

• Former Veridian site and complex.
• Site zoned Office Research & Laboratory (ORL).
• Majority of the site is highly developable land.

More Real Estate Listings
Feature

Hot Company

Helsinn Therapeutics (US) Inc.
1160 US Highway 22, Suite 104
Bridgewater, New Jersey 08807 U.S.A.
Phone: 908-203-6549 Fax: 908-231-1459

Helsinn Therapeutics (US) Inc. is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA.
Events

Tax Planning for the Biotech & Pharmaceutical Industries
La Jolla Shores Hotel
August 8 & 9, 2011

In the past few years, very significant tax changes have occurred in the Pharmaceutical and Biotech industries. Recent developments in contract manufacturing, supply chain management, the treatment of intellectual property, and repatriation of intellectual property back to the U.S. are a few of the significant developments that will address, as well as, the finalized cost sharing regulations. Learn how these new developments, opportunities and pitfalls will impact stocks and intangible assets. Our panel of experts will discuss recent legislation, tax credits, IRS implications and recent activity by the IRS towards audit procedures.

For more information, please visit: www.networkingseminars.net/biotech.
 
Top Jobs
BioMidwest (Indianapolis, Indiana)

Watson Pharmaceuticals, Inc.
Strategic Account Specialist
Under general supervision, responsible for all aspects of product promotion for products that may require an "account management" type of selling skill. This would be accomplished through an increased demonstration of the competency of conceptual thinking as it applies to data management and business planning.

Biotech Beach (Temecula, California)

Millipore Corporation
Financial Analyst; Bioscience Business Field
Will act as the principal financial advisor to the Business Field Controller. The analyst will coordinate financial activities within the business field and liaise with local finance organization in order to obtain local financials and business insights.

Biotech Bay (Santa Clara, California)

Affymetrix
Manager, Marketing Operations
Responsible for management of full vertical support for Eloqua lead management marketing system. Drives email marketing campaigns, lead nurturing programs and ROI metric reporting. Etc.

BioCapital (Gaithersburg, Maryland)

MedImmune, LLC
Market Development Specialist
Manages the Incentive Compensation planning process through strategic thinking, presenting ideas and analysis while working in conjunction with the Core and Steering teams. Etc.

Genetown (Weston, Massachusetts)

Biogen Idec
Associate Director, Global Strategy - Interferon Franchise
This position is responsible for leading the development and execution of the Global Interferon Franchise Strategy and Execution. Lead strategy in alignment with overall AVONEX brand strategy.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!

Career Fairs

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, San Diego, CA September 22, 2011
BioMidwest Career Fair, Chicago, IL October 4, 2011
Pharm Country Career Fair, Bridgewater, NJ October 5, 2011
Biotech Bay Career Fair, Burlingame, CA October 11, 2011
Bio NC Career Fair, Durham, NC October 20, 2011
BioCapital Beach Career Fair, Bethesda, MD November 1, 2011
Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the BioSpace Deals & Dollars here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


Panel Backs FDA Pulling Plug on Avastin - June 30, 2011

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, June 30, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS

TOP SPONSOR

Reduce Risk and Maximize Potential in Ophthalmology Development:

Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.

The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA +1-713-559-7900, UK +44-0-1344-891121.
HeadHtml
•   Panel Backs FDA Pulling Plug on Avastin More...
•  Doctors to FDA: Gilead Sciences, Inc. (GILD)'s "HIV Prevention Pill" Not Ready for Approval More...
•  VIVUS, Inc. (VVUS) Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction More...
•  FDA Accepts Submission of New Drug Application for Corcept Therapeutics Inc. (CORT)'s CORLUX for Cushing's Syndrome More...
•  Forest Laboratories, Inc. (FRX) and Almirall Announce Submission of New Drug Application for Aclidinium Bromide for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) More...

More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Sagent Pharmaceuticals, Inc. Announces FDA Approval of Polymyxin B for Injection, USP More...

More Drug Approval News
HeadHtml
•  Endo Pharmaceuticals (ENDP) 's Lower Back Pain Drug Fails Trial; Drug Did Not Meet Mid-stage Trial Goals More...
•  Nuvo Research Inc. (NRI.TO) Announces Positive Top-Line Results for Pennsaid Viscous Solution Phase 2 Trial More...
•  Medicago, Inc. Announces Positive Top-Line Results for Pennsaid Viscous Solution Phase 2 Trial More...
•  Vectura Group plc Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD More...
•  ACORN Research Reports Positive Findings of Phase 2b Metastatic Breast Cancer Trial at ASCO More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  Natural Gases as a Therapy for Heart Disease, University of Exeter and National University of Singapore (NUS) Study More...
•  Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors, Dana-Farber Cancer Institute Study More...
•  New Therapy for Childhood Neuroblastoma Proves Feasible and Safe, Study in The Journal of Nuclear Medicine Finds More...
•  Possible Way to Make Bladder Cancer Cells More Susceptible to Chemotherapy, University of California, Davis (UCD) Study More...
•  Inovio Pharmaceuticals (INO)' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study More...

More General Clinical Research News
Events

Join us for the 40th Annual Meeting of the American College of Clinical Pharmacology, Sept. 11-13, 2011 at the Crowne Plaza Chicago O'Hare Hotel, Chicago (Rosemont), IL, covering a wide range of current, relevant topics as noted below. CME and CPE credits available for registered attendees.

• Transdermal Delivery Systems
• Opioids and Psychotropic Drugs
• First-in-Human Clinical Trials
• Model-based Drug Development
• Biotherapeutic Dose Selection Strategies
• Drug Safety vs. Disease Treatment
• Quantitative Clinical Pharmacology in Inflammation & Immunology
• Imaging Techniques in Drug Development
• Bridging Clinical Trials
• Innovations in Pharmacoepideomiology
• Hormone Therapy in Menopausal Women

Keynote speakers include: Francis S. Collins, MD, PhD, Director of the National Institutes of Health (NIH) on Sunday, Sept 11th and Anne Schuchat, MD, Director of the CDC's National Center for Immunization and Respiratory Diseases (NICRD) on Monday, Sept 12th.

Additional information about the ACCP 40th Annual Meeting and the Preliminary Program are available online or contact TStevens@ACCP1.org.
Latest Market Insight

Advances in Drug-Diagnostic Co-Development

• Understand the current regulatory environment for both diagnostics and drugs within the EU and the US and how these relate to their co-development.
• Understand the biomarker discovery and validation process.
• Using case studies discover how drugs and their companion diagnostics have already received approval in the US and EU.

Click Here for More Information
Tower: Facebook

Top Jobs
Biotech Beach (Irvine, California)

Edwards Life Sciences
Clinical Research Associate
Oversight of all study documentation review (for completeness), filing and tracking activities to ensure compliance. This includes the Master files, Site file and Business files for THV each study. Etc.

Biotech Bay (Newark, California)

Synarc, Inc.
Clinical Data Manager
Provides accurate, timely, and consistent clinical data to client organizations and internal staff to support business objectives. The Clinical Data Manager defines and directs the data management workflow. Etc.

Genetown (Rockville, Maryland)

Novartis Institutes for BioMedical Research, Inc.
BS/MS Level In Vivo Biologist: Oncology Research
The successful candidate will join a dynamic, multi-disciplinary team of scientists in the In Vivo Pharmacology Oncology Department, playing a key role in the development of in vivo models of cancer and the use of those models for evaluating new drug candidates.

Pharm Country (Ridgefield, Connecticut)

Kforce Clinical Research
Clinical Research Associate
To collaborate in the identification and drive the selection of investigator sites with input from other cross-functional groups. Also monitors investigator sites in compliance with company SOPs, ICH/GCP and local laws so that site performance targets are achieved. Etc.

BioMidwest (Deerfield, Illinois)

Astellas Pharma US
Associate Director, Clinical Studies
Responsible for overseeing the management of multiple clinical development programs that typically involve multiple therapeutic areas or indications. Provides direction to Senior Managers and Study Managers and clinical teams. Etc.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, San Diego, CA September 22, 2011
BioMidwest Career Fair, Chicago, IL October 4, 2011
Pharm Country Career Fair, Bridgewater, NJ October 5, 2011
Biotech Bay Career Fair, Burlingame, CA October 11, 2011
Bio NC Career Fair, Durham, NC October 20, 2011
BioCapital Beach Career Fair, Bethesda, MD November 1, 2011
Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Forest Laboratories, Inc. (FRX) Announces Commercial Availability of VIIBRYD(TM) in Pharmacies More...
•  Malaria Parasite and Mosquito Products and Assay Services Available for Sale by Sanaria Inc. More...

More Drug Product News
Feature

Hot Company

Idenix Pharmaceuticals, Inc.
60 Hampshire Street
Cambridge, Massachusetts 02139 U.S.A.
Phone: 617-995-9800 Fax: 617-995-9801

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.